The federal government’s insistence on partnering with a Chinese vaccine company in the early stages of the pandemic led to a nearly two-year delay in producing a Canada-made vaccine, according to a new report. The Canadian government waited months for a COVID-19 vaccine sample to arrive from China that never materialized, and wasted millions upgrading a facility that has never produced any vaccines, according to government documents obtained by CBC’s The Fifth Estate. The documents show that in May 2020, the National Research Council of Canada (NRC) signed a collaboration agreement with the Chinese company CanSino Biologics to “fast-track” a COVID-19 vaccine for emergency use in Canada. CanSino, which is affiliated with the Chinese Communist Party (CCP) and its military, was to ship the vaccines to Canada for further clinical trials that month. The NRC had been preparing to manufacture the vaccines and committed $44 million to upgrade a temporary production …